Patches have long been a tool used in helping people quit smoking. Now, thanks to researchers at Brigham and Women's Hospital, they may one day be able to shrink cancerous tumors.

When treating a stoke every seconds counts especially when attempting to administer tPA, but the problem is the time it takes neurologists to see if the patient is even in need of tPA is time the patient doesn’t have. To combat these problems Kaiser Permanente implemented their telestroke program and the results show an increase in tPA use by 73 percent. 

Yeast may not be the most exciting thing found in your kitchen, but for biopharmaceutical drugs, it’s the base of the pyramid. 

According to the journal Nature, new research shows that some humans are self-equipped with a method to kill a particularly deadly superbug. 

In the first national survey on health care services in prisons conducted by the Centers for Disease Control and Prevention (CDC), the agency found some inconsistency in how care is provided to a population which has higher rates of mental illness, chronic conditions and infectious diseases.

A team of researchers led by Teresa Przytycka, PhD, a National Institutes of Health investigator, has developed new technological tool that can identify binding molecules with the highest precision.

Stepping into the world of DNA synthesis is Cambridge Consultants, a product development and technology consultancy company, based in the United Kingdom. Launching its own subsidiary company, Evonetix, Cambridge hopes to be a leading provider of synthetic biology products. 

Because Parkland Memorial Hospital in Dallas plans to build a new 2.8 million-square-foot facility (one of the biggest single-location hospitals in the country), the hospital's IT staff knew it was time for them to build a new technological system to go with it.